Cargando…

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges

Fibrinogen is one of the key molecular players in haemostasis. Thrombin-mediated release of fibrinopeptides from fibrinogen converts this soluble protein into a network of fibrin fibres that form a building block for blood clots. Thrombin-activated factor XIII further crosslinks the fibrin fibres an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaule, Thembaninkosi G., Ajjan, Ramzi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268464/ https://www.ncbi.nlm.nih.gov/pubmed/34203139 http://dx.doi.org/10.3390/ijms22136916

Ejemplares similares

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
por: Kołodziejczyk, Joanna, et al.
Publicado: (2013)

Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
por: Page, Martin J., et al.
Publicado: (2019)

Fibrin(ogen) mediates acute inflammatory responses to biomaterials
Publicado: (1993)

Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
por: Wen, Tingting, et al.
Publicado: (2023)

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear
por: Berny, Michelle A., et al.
Publicado: (2010)

In vitro characterization of jellyfish venom fibrin(ogen)olytic enzymes from Nemopilema nomurai
por: Bae, Seong Kyeong, et al.
Publicado: (2017)

Fibrin(ogen) Is Constitutively Expressed by Differentiated Intestinal Epithelial Cells and Mediates Wound Healing
por: Seltana, Amira, et al.
Publicado: (2022)

Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition
por: Fox, Tilly, et al.
Publicado: (2023)

The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6
por: Cole, Heather A., et al.
Publicado: (2021)

Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species
por: Petraglia, Tania, et al.
Publicado: (2022)

FITC-linked Fibrin-Binding Peptide and real-time live confocal microscopy as a novel tool to visualize fibrin(ogen) in coagulation
por: Weiss, Nikolaj, et al.
Publicado: (2017)

CD44–fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition
por: Wang, Chunxu, et al.
Publicado: (2022)

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
por: Altalhi, Rawan, et al.
Publicado: (2021)

Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
por: Grobler, Corlia, et al.
Publicado: (2020)

Fibrin(ogen) engagement of S. aureus promotes the host antimicrobial response and suppression of microbe dissemination following peritoneal infection
por: Negrón, Oscar, et al.
Publicado: (2022)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Isolation from Gloydius blomhoffii siniticus Venom of a Fibrin(ogen)olytic Enzyme Consisting of Two Heterogenous Polypeptides
por: Choi, Suk-Ho, et al.
Publicado: (2013)

Dual Function of a Bee Venom Serine Protease: Prophenoloxidase-Activating Factor in Arthropods and Fibrin(ogen)olytic Enzyme in Mammals
por: Choo, Young Moo, et al.
Publicado: (2010)

A Bi-Functional Anti-Thrombosis Protein Containing Both Direct-Acting Fibrin(ogen)olytic and Plasminogen-Activating Activities
por: Yang, Hailong, et al.
Publicado: (2011)

Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets
por: Sagar, Rebecca C., et al.
Publicado: (2022)

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model
por: Turner, Simone, et al.
Publicado: (2023)

Integrative Cancer Genomics (IntOGen) in Biomart
por: Perez-Llamas, Christian, et al.
Publicado: (2011)

Urinary Plasmin(ogen): New Predictor of Hypertension?
por: Kohan, Donald E.
Publicado: (2018)

Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension
por: Ray, Evan C., et al.
Publicado: (2018)

SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19
por: Grobbelaar, Lize M., et al.
Publicado: (2021)

Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin(ogen)olytic serine protease from leaves of Leucas indica
por: Gogoi, Debananda, et al.
Publicado: (2018)

Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
por: Xiong, Wei-Xin, et al.
Publicado: (2015)

Exploring the Fibrin(ogen)olytic, Anticoagulant, and Antithrombotic Activities of Natural Cysteine Protease (Ficin) with the κ-Carrageenan-Induced Rat Tail Thrombosis Model
por: Yang, Hye Ryeon, et al.
Publicado: (2022)

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
por: Pechlivani, Nikoletta, et al.
Publicado: (2021)

Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
por: Gauer, Julia S., et al.
Publicado: (2022)

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis
por: Sobczak, Amélie I. S., et al.
Publicado: (2020)

DEER and RIDME Measurements of the Nitroxide-Spin Labelled Copper-Bound Amine Oxidase Homodimer from Arthrobacter Globiformis
por: Russell, Hannah, et al.
Publicado: (2021)

Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure
por: Neergaard-Petersen, Søs, et al.
Publicado: (2013)

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study
por: Panoutsopoulou, K, et al.
Publicado: (2010)

The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk
por: Safdar, Nawaz Z., et al.
Publicado: (2023)

Beneficial and Detrimental Effects of Plasmin(ogen) during Infection and Sepsis in Mice
por: Guo, Yongzhi, et al.
Publicado: (2011)

IntOGen-mutations identifies cancer drivers across tumor types
por: Gonzalez-Perez, Abel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nmcuf7s2km897cbvs0ima0dhlv